These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.


  • J0485

    Injection, belatacept, 1 mg
  • J0490

    Injection, belimumab, 10 mg
  • J0491

    Injection, anifrolumab-fnia, 1 mg
  • J0500

    Injection, dicyclomine hcl, up to 20 mg
  • J0515

    Injection, benztropine mesylate, per 1 mg
  • J0517

    Injection, benralizumab, 1 mg
  • J0520

    Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg
  • J0525

    Injection, cefotetan disodium, 10 mg
  • J0558

    Injection, penicillin g benzathine and penicillin g procaine, 100,000 units
  • J0561

    Injection, penicillin g benzathine, 100,000 units


  • Continued
  • J0565

    Injection, bezlotoxumab, 10 mg
  • J0567

    Injection, cerliponase alfa, 1 mg
  • J0570

    Buprenorphine implant, 74.2 mg
  • J0571

    Buprenorphine, oral, 1 mg
  • J0572

    Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine
  • J0573

    Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
  • J0574

    Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine
  • J0575

    Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine
  • J0576

    Injection, buprenorphine extended-release (brixadi), 1 mg
  • J0577

    Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
  • J0578

    Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy
  • J0582

    Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg
  • J0583

    Injection, bivalirudin, 1 mg
  • J0584

    Injection, burosumab-twza 1 mg
  • J0585

    Injection, onabotulinumtoxina, 1 unit
  • J0586

    Injection, abobotulinumtoxina, 5 units
  • J0587

    Injection, rimabotulinumtoxinb, 100 units
  • J0588

    Injection, incobotulinumtoxin a, 1 unit
  • J0589

    Injection, daxibotulinumtoxina-lanm, 1 unit
  • J0591

    Injection, deoxycholic acid, 1 mg


  • Continued
  • J0592

    Injection, buprenorphine hydrochloride, 0.1 mg
  • J0593

    Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
  • J0594

    injection, busulfan, 1 mg
  • J0595

    Injection, butorphanol tartrate, 1 mg
  • J0596

    Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units
  • J0597

    Injection, c-1 esterase inhibitor (human), berinert, 10 units
  • J0598

    Injection, c-1 esterase inhibitor (human), cinryze, 10 units
  • J0599

    Injection, c-1 esterase inhibitor (human), (haegarda), 10 units
  • J0600

    Injection, edetate calcium disodium, up to 1000 mg
  • J0601

    Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
  • J0602

    Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)
  • J0603

    Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
  • J0604

    Cinacalcet, oral, 1 mg, (for esrd on dialysis)
  • J0605

    Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)
  • J0606

    Injection, etelcalcetide, 0.1 mg
  • J0607

    Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)
  • J0608

    Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)
  • J0609

    Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)
  • J0610

    Injection, calcium gluconate (fresenius kabi), per 10 ml
  • J0611

    Injection, calcium gluconate (wg critical care), per 10 ml